Caveolae, caveolins, cavins, and endothelial cell function: New insights

Frontiers in Physiology

Volumn 2 JAN, Issue , 2012, Pages

  Sowa, Grzegorz ^a  

^a University of Missouri   (United States)

Author keywords

Caveolae; Caveolin 1; Caveolin 2; Cavins; Endothelial cell

Indexed keywords

EID: 84866298370     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00120     Document Type: Article

References (146)

1. Albinsson, S., Nordstrom, I., Sward, K., and Hellstrand, P. (2008). Differential dependence of stretch and shear stress signaling on caveolin-1 in the vascular wall. Am. J. Physiol. Cell Physiol. 294, C271-C279.
2. Albinsson, S., Shakirova, Y., Rippe, A., Baumgarten, M., Rosengren, B. I., Rippe, C., Hallmann, R., Hellstrand, P., Rippe, B., and Sward, K. (2007). Arterial remodeling and plasma volume expansion in caveolin-1-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1222- R1231.
3. Allen, J. A., Halverson-Tamboli, R. A., and Rasenick, M. M. (2007). Lipid raft microdomains and neurotrans-mitter signalling. Nat. Rev. Neurosci. 8, 128-140.
4. Anderson,R. G. (1993). Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. U.S.A. 90, 10909-10913.
5. Anderson, R. G., Kamen, B. A., Roth-berg, K. G., and Lacey, S. W. (1992). Potocytosis: sequestration and transport of small molecules by caveolae. Science 255, 410-411.
6. Barresi, V., Cerasoli, S., and Tuccari, G. (2008). Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology 28, 472-478.
7. Bastiani, M., Liu, L., Hill, M. M., Jedrychowski, M. P., Nixon, S. J., Lo, H. P., Abankwa, D., Luetterforst, R., Fernandez-Rojo, M., Breen, M. R., Gygi, S. P., Vinten, J., Walser, P. J., North, K. N., Hancock, J. F., Pilch, P. F., and Parton, R. G. (2009). MURC/Cavin-4 and cavin family members form tissue-specific cave-olar complexes. J. Cell Biol. 185, 1259-1273.
8. Beardsley, A., Fang, K., Mertz, H., Cas-tranova, V., Friend, S., and Liu, J. (2005). Loss of caveolin-1 polarity impedes endothelial cell polarization and directional movement. J. Biol. Chem. 280, 3541-3547.
9. Bernatchez, P., Sharma, A., Bauer, P. M., Marin, E., and Sessa, W. C. (2011). A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice. J. Clin. Invest. 121, 3747-3755.
10. Brandes, R. P., Fleming, I., and Busse, R. (2005). Endothelial aging. Cardio-vasc. Res. 66, 286-294.
11. Briand, N., Dugail, I., and Le Lay, S. (2011a). Cavin proteins: new players in the caveolae field. Biochimie 93, 71-77.
12. Briand, N., Le Lay, S., Sessa, W. C., Ferre, P., and Dugail, I. (2011b). Distinct roles of endothelial and adipocyte caveolin-1 in macrophage infiltration and adipose tissue metabolic activity. Diabetes 60, 448-453.
13. Brouet, A., DeWever, J., Martinive, P., Havaux, X., Bouzin, C., Sonveaux, P., and Feron, O. (2005). Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodila-tory effects of nitric oxide. FASEB J. 19, 602-604.
14. Bucci, M., Gratton, J. P., Rudic, R. D., Acevedo, L., Roviezzo, F., Cirino, G., and Sessa, W. C. (2000). In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat. Med. 6, 1362-1367.
15. Chang, S. H., Feng, D., Nagy, J. A., Sciuto,T. E.,Dvorak,A. M.,and Dvorak, H. F. (2009). Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am. J. Pathol. 175, 1768-1776.
16. Cohen, A. W., Park, D. S., Woodman, S. E., Williams, T. M., Chandra, M., Shirani, J., Pereira de Souza, A., Kit-sis, R. N., Russell, R. G., Weiss, L. M., Tang, B., Jelicks, L. A., Factor, S. M., Shtutin, V., Tanowitz, H. B., and Lisanti, M. P. (2003). Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 284, C457-C474.
17. Davalos, A., Fernandez-Hernando, C., Sowa, G., Derakhshan, B., Lin, M. I., Lee, J. Y., Zhao, H., Luo, R., Colangelo, C., and Sessa, W. C. (2010). Quantitative proteomics of caveolin-1-regulated proteins: characterization of polymerase i and transcript release factor/CAVIN-1 IN endothelial cells. Mol. Cell Pro-teomics 9, 2109-2124.
18. de Laurentiis, A., Donovan, L., and Arcaro, A. (2007). Lipid rafts and caveolae in signaling by growth factor receptors. Open Biochem. J. 1, 12-32.
19. Desjardins, F., Lobysheva, I., Pelat, M., Gallez, B., Feron, O., Dessy, C., and Balligand, J. L. (2008). Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis. Cardio-vasc. Res. 79, 527-536.
20. Dewever, J., Frerart, F., Bouzin, C., Baudelet, C., Ansiaux, R., Sonveaux, P., Gallez, B., Dessy, C., and Feron, O. (2007). Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment. Am. J. Pathol. 171, 1619-1628.
21. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., Schedl, A., Haller, H., and Kurzchalia, T. V. (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452.
22. Dubroca, C., Loyer, X., Retailleau, K., Loirand, G., Pacaud, P., Feron, O., Balligand, J. L., Levy, B. I., Heymes, C., and Henrion, D. (2007). RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovasc. Res. 73, 190-197.
23. Durante, W., Kroll, M. H. Christodoulides, N., Peyton, K. J., and Schafer, A. I. (1997). Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80, 557-564.
24. Durr, E., Yu, J., Krasinska, K. M., Carver L. A., Yates, J. R., Testa, J. E., Oh, P. and Schnitzer, J. E. (2004). Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat. Biotechnol. 22, 985-992.
25. Fang, K., Fu, W., Beardsley, A. R. Sun, X., Lisanti, M. P., and Liu, J. (2007). Overexpression of caveolin-1 inhibits endothelial cell proliferation by arresting the cell cycle at G0/G1 phase. Cell Cycle 6, 199-204.
26. Fernandez-Hernando, C., Yu, J., Dava-los, A., Prendergast, J., and Sessa, W. C. (2010). Endothelial-specific over-expression of caveolin-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 177 998-1003.
27. Fernandez-Hernando, C., Yu, J., Suarez Y., Rahner, C., Davalos, A., Lasun-cion, M. A., and Sessa, W. C. (2009). Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab. 10, 48-54.
28. Feron, O., Belhassen, L., Kobzik, L. Smith, T. W., Kelly, R. A., and Michel, T. (1996). Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J. Biol. Chem. 271 22810-22814.
29. Fielding, P. E., and Fielding, C. J. (1995). Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34, 14288-14292.
30. Frank, P. G., Lee, H., Park, D. S., Tandon N. N., Scherer,P.E.,and Lisanti,M.P. (2004). Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 98-105.
31. Frank, P. G., Pavlides, S., Cheung, M. W., Daumer, K., and Lisanti, M. P. (2008). Role of caveolin-1 in the regulation of lipoprotein metabolism. Am. J. Physiol. Cell Physiol. 295, C242-C248.
32. Fujimoto, T., Kogo, H., Nomura, R., and Une, T. (2000). Isoforms of caveolin-1 and caveolar structure. J. Cell. Sci. 113(Pt 19), 3509-3517.
33. Galvez, B. G., Matias-Roman, S., Yanez-Mo, M., Vicente-Manzanares, M., Sanchez-Madrid, F., and Arroyo, A. G. (2004). Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol. Biol. Cell 15, 678-687.
34. Garcia-Cardena, G., Martasek, P., Masters, B. S., Skidd, P. M., Couet, J., Li, S., Lisanti, M. P., and Sessa, W. C. (1997). Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J. Biol. Chem. 272, 25437-25440.
35. Garrean, S., Gao, X. P., Brovkovych, V., Shimizu, J., Zhao, Y. Y., Vogel, S. M., and Malik, A. B. (2006). Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J. Immunol. 177, 4853-4860.
36. Ge, S., Song, L., Serwanski, D. R., Kuziel, W. A., and Pachter, J. S. (2008). Transcellular transport of CCL2 across brain microvascular endothelial cells. J. Neurochem. 104, 1219-1232.
37. Ghitescu, L., Fixman, A., Simionescu, M., and Simionescu, N. (1986). Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothe-lium: receptor-mediated transcyto-sis. J. Cell Biol. 102, 1304-1311.
38. Glenney, J. R. Jr., and Soppet, D. (1992). Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phos-phorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 89, 10517-10521.
39. Griffoni, C., Spisni, E., Santi, S., Ric-cio, M., Guarnieri, T., and Tomasi, V. (2000). Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 276, 756-761.
40. Hansen, C. G., Bright, N. A., Howard, G., and Nichols, B. J. (2009). SDPR induces membrane curvature and functions in the formation of caveo-lae. Nat. Cell Biol. 11, 807-814.
41. Hansen, C. G., and Nichols, B. J. (2010). Exploring the caves: cavins,caveolins and caveolae. Trends Cell Biol. 20, 177-186.
42. Hartmannsgruber, V., Heyken, W. T., Kacik, M., Kaistha, A., Grgic, I., Harteneck, C., Liedtke, W., Hoyer, J., and Kohler, R. (2007). Arterial response to shear stress critically depends on endothelial TRPV4 expression. PLoS ONE 2, e827. doi:10.1371/journal.pone.0000827
43. Hayer, A., Stoeber, M., Bissig, C., and Helenius, A. (2010). Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes. Traffic 11, 361-382.
44. Hill, M. M., Bastiani, M., Luetter-forst, R., Kirkham, M., Kirkham, A., Nixon, S. J., Walser, P., Abankwa, D., Oorschot, V. M., Martin, S., Hancock, J. F., and Parton, R. G. (2008). PTRF-Cavin, a conserved cytoplas-mic protein required for caveola formation and function. Cell 132, 113-124.
45. Hu, G., Vogel, S. M., Schwartz, D. E., Malik, A. B., and Min-shall, R. D. (2008a). Intercellular adhesion molecule-1-dependent neutrophil adhesion to endothelial cells induces caveolae-mediated pulmonary vascular hyperpermeability. Circ. Res. 102, e120-e131.
46. Hu, G., Ye, R. D., Dinauer, M. C., Malik, A. B., and Minshall, R. D. (2008b). Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. Am. J. Physiol. Lung Cell Mol. Physiol. 294, L178-L186.
47. Ingbar, D. H. (2000). Mechanisms of repair and remodeling following acute lung injury. Clin. Chest Med. 21, 589-616.
48. Insel, P. A., and Patel, H. H. (2007). Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'lost proteins'? Br. J. Pharmacol. 150, 251-254.
49. Insel, P. A., and Patel, H. H. (2009). Membrane rafts and caveolae in cardiovascular signaling. Curr. Opin. Nephrol. Hypertens. 18, 50-56.
50. Isshiki, M., and Anderson, R. G. (1999). Calcium signal transduction from caveolae. Cell Calcium 26, 201-208.
51. Iwakiri, Y., Satoh, A., Chatterjee, S., Toomre, D. K., Chalouni, C. M., Fulton, D., Groszmann, R. J., Shah, V. H., and Sessa, W. C. (2006). Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc. Natl. Acad. Sci. U.S.A. 103, 19777-19782.
52. Jin, S., Zhang, Y., Yi, F., and Li, P. L. (2008a). Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arte-rioscler. Thromb. Vasc. Biol. 28, 485-490.
53. Jin, Y., Kim, H. P., Chi, M., Ifedigbo, E., Ryter, S. W., and Choi, A. M. (2008b). Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. Am. J. Respir. Cell Mol. Biol. 39, 171-179.
54. Jin, Y., Lee, S. J., Minshall, R. D., and Choi, A. M. (2011). Caveolin-1: a critical regulator of lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L151-L160.
55. Joo, H. J., Oh, D. K., Kim, Y. S., Lee, K. B., and Kim, S. J. (2004). Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int. 93, 291-296.
56. Ju, H., Zou, R., Venema, V. J., and Ven-ema, R. C. (1997). Direct interaction of endothelial nitric-oxide syn-thase and caveolin-1 inhibits syn-thase activity. J. Biol. Chem. 272, 18522-18525.
57. Kim, H. P., Wang, X., Galbiati, F., Ryter, S. W., and Choi, A. M. (2004). Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J. 18, 1080-1089.
58. Kim, S., Lee, Y., Seo, J. E., Cho, K. H., and Chung, J. H. (2008). Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts. Cell. Signal. 20, 1313-1319.
59. King, G. L., and Johnson, S. M. (1985). Receptor-mediated transport of insulin across endothelial cells. Science 227, 1583-1586.
60. Kohler, R., Heyken, W. T., Heinau, P., Schubert, R., Si, H., Kacik, M., Busch, C., Grgic, I., Maier, T., and Hoyer, J. (2006). Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation. Arterioscler. Thromb. Vasc. Biol. 26, 1495-1502.
61. Kurzchalia, T. V., Dupree, P., Parton, R. G., Kellner, R., Virta, H., Lehnert, M., and Simons, K. (1992). VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell Biol. 118, 1003-1014.
62. Kwiatek, A. M., Minshall, R. D., Cool, D. R., Skidgel, R. A., Malik, A. B., and Tiruppathi, C. (2006). Caveolin-1 regulates store-operated Ca2+ influx by binding of its scaffolding domain to transient receptor potential channel-1 in endothelial cells. Mol. Pharmacol. 70, 1174-1183.
63. Labrecque, L., Royal, I., Surprenant, D. S., Patterson, C., Gingras, D., and Beliveau, R. (2003). Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol. Biol. Cell 14, 334-347.
64. Lahtinen, U., Honsho, M., Parton, R. G., Simons, K., and Verkade, P. (2003). Involvement of caveolin-2 in caveo-lar biogenesis in MDCK cells. FEBS Lett. 538, 85-88.
65. Lee, H., Park, D. S., Wang, X. B., Scherer, P. E., Schwartz, P. E., and Lisanti, M. P. (2002). Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1. J. Biol. Chem. 277, 34556-34567.
66. Li, P. L., Zhang, Y., and Yi, F. (2007). Lipid raft redox signaling platforms in endothelial dysfunction. Antioxid. Redox Signal. 9, 1457-1470.
67. Lin, M. I., Yu, J., Murata, T., and Sessa, W. C. (2007). Caveolin-1-deficient mice have increased tumor microvascular permeability, angio-genesis, and growth. Cancer Res. 67, 2849-2856.
68. Liu, J., Wang, X. B., Park, D. S., and Lisanti, M. P. (2002). Caveolin-1 expression enhances endothelial capillary tubule formation. J. Biol. Chem. 277, 10661-10668.
69. Liu, L., and Pilch, P. F. (2008). A critical role of cavin (poly-merase I and transcript release factor) in caveolae formation and organization. J. Biol. Chem. 283, 4314-4322.
70. Luscher, T. F., and Noll, G. (1994). Endothelium dysfunction in the coronary circulation. J. Cardiovasc. Pharmacol. 24(Suppl. 3), S16-S26.
71. Mantell, L. L., and Lee, P. J. (2000). Signal transduction pathways in hyperoxia-induced lung cell death. Mol. Genet. Metab. 71, 359-370.
72. Matute-Bello, G., Frevert, C. W., and Martin, T. R. (2008). Animal models of acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L379- L399.
73. McMahon, K. A., Zajicek, H., Li, W. P., Peyton, M. J., Minna, J. D., Hernandez, V. J., Luby-Phelps, K., and Anderson, R. G. (2009). SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J. 28, 1001-1015.
74. Mehta, D., Bhattacharya, J., Matthay, M. A., and Malik, A. B. (2004). Integrated control of lung fluid balance. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L1081-L1090.
75. Michel, J. B., Feron, O., Sacks, D., and Michel, T. (1997). Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J. Biol. Chem. 272, 15583-15586.
76. Milovanova, T., Chatterjee, S., Hawkins, B. J., Hong, N., Sorokina, E. M., Debolt, K., Moore, J. S., Madesh, M., and Fisher,A. B. (2008). Caveolae are an essential component of the pathway for endothelial cell signaling associated with abrupt reduction of shear stress. Biochim. Biophys. Acta 1783, 1866-1875.
77. Mirza, M. K., Yuan, J., Gao, X. P., Gar-rean, S., Brovkovych, V., Malik, A. B., Tiruppathi, C., and Zhao, Y. Y. (2010). Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation. Am. J. Pathol. 176, 2344-2351.
78. Miyawaki-Shimizu, K., Predescu, D., Shimizu, J., Broman, M., Predescu, S., and Malik, A. B. (2006). siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L405-L413.
79. Murata, T., Lin, M. I., Huang, Y., Yu, J., Bauer, P. M., Giordano, F. J., and Sessa, W. C. (2007a). Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J. Exp. Med. 204, 2373-2382.
80. Murata, T., Lin, M. I., Stan, R. V., Bauer, P. M., Yu, J., and Sessa, W. C. (2007b). Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. J. Biol. Chem. 282, 16631-16643.
81. Nilius, B., Droogmans, G., and Won-dergem, R. (2003). Transient receptor potential channels in endothe-lium: solving the calcium entry puzzle? Endothelium 10, 5-15.
82. Ogata, T., Ueyama, T., Isodono, K., Tagawa, M., Takehara, N., Kawashima, T., Harada, K., Taka-hashi, T., Shioi, T., Matsubara, H., and Oh, H. (2008). MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance. Mol. Cell. Biol. 28, 3424-3436.
83. Ogi, M., Yokomori, H., Oda, M., Yoshimura, K., Nomura, M., Ohshima, S., Akita, M., Toda, K., and Ishii, H. (2003). Distribution and localization of caveolin-1 in sinusoidal cells in rat liver. Med. Electron. Microsc. 36, 33-40.
84. Oh, P., Borgstrom, P., Witkiewicz, H., Li, Y., Borgstrom, B. J., Chrastina, A., Iwata, K., Zinn, K. R., Baldwin, R., Testa, J. E., and Schnitzer, J. E. (2007). Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat. Biotechnol. 25, 327-337.
85. Palade, G. E. (1953). Fine structure of blood capillaries. J. Appl. Phys. 24, 1424.
86. Palade, G. E. (1961). Blood capillaries of the heart and other organs. Circulation. 24, 368-384.
87. Palade, G. E., and Bruns, R. R. (1968). Structural modulations of plas-malemmal vesicles. J. Cell Biol. 37, 633-649.
88. Pani, B., and Singh, B. B. (2009). Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium 45, 625-633.
89. Park, H., Go, Y. M., St John, P. L., Maland, M. C., Lisanti, M. P., Abra-hamson, D. R., and Jo, H. (1998). Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J. Biol. Chem. 273, 32304-32311.
90. Parton, R. G. (1996). Caveolae and caveolins. Curr. Opin. Cell Biol. 8, 542-548.
91. Parton, R. G., and Simons, K. (2007). The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8, 185-194.
92. Patel, H. H., Murray, F., and Insel, P. A. (2008). Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu. Rev. Pharmacol. Toxicol. 48, 359-391.
93. Predescu, D., Vogel, S. M., and Malik, A. B. (2004). Functional and morphological studies of protein transcyto-sis in continuous endothelia. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L895-L901.
94. Rahman, A., and Sward, K. (2009). The role of caveolin-1 in cardiovascular regulation. Acta Physiol. (Oxf.) 195, 231-245.
95. Rajab, A., Straub, V., McCann, L. J., Seelow, D., Varon, R., Barresi, R., Schulze, A., Lucke, B., Lutzk-endorf, S., Karbasiyan, M., Bach-mann, S., Spuler, S., and Schuelke, M. (2010). Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet. 6, e1000874. doi:10.1371/journal.pgen.1000874
96. Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., Di Vizio, D., Hou, H. Jr., Kneitz, B., Lagaud, G., Christ, G. J., Edelmann, W., and Lisanti, M. P. (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121-38138.
97. Razani, B., Wang, X. B., Engelman, J. A., Battista, M., Lagaud, G., Zhang, X. L., Kneitz, B., Hou, H. Jr., Christ, G. J., Edelmann, W., and Lisanti, M. P. (2002). Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol. Cell. Biol. 22, 2329-2344.
98. Rippe, B., Rosengren, B. I., Carls-son, O., and Venturoli, D. (2002). Transendothelial transport: the vesicle controversy. J. Vasc. Res. 39, 375-390.
99. Rizzo, V., McIntosh, D. P., Oh, P., and Schnitzer, J. E. (1998a). In situ flow activates endothelial nitric oxide synthase in luminal cave-olae of endothelium with rapid caveolin dissociation and calmod-ulin association. J. Biol. Chem. 273, 34724-34729.
100. Rizzo, V., Sung, A., Oh, P., and Schnitzer, J. E. (1998b). Rapid mechanotrans-duction in situ at the luminal cell surface of vascular endothelium and its caveolae. J. Biol. Chem. 273, 26323-26329.
101. Rosengren, B. I., Rippe, A., Rippe, C., Venturoli, D., Sward, K., and Rippe, B. (2006). Transvascular protein transport in mice lacking endothelial caveolae. Am. J. Physiol. Heart Circ. Physiol. 291, H1371-H1377.
102. Ross, R. (1999). Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126.
103. Saliez, J., Bouzin, C., Rath, G., Ghisdal, P., Desjardins, F., Rez-zani, R., Rodella, L. F., Vriens, J., Nilius, B., Feron, O., Balli-gand, J. L., and Dessy, C. (2008). Role of caveolar compartmentation in endothelium-derived hyperpo-larizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells. Circulation 117, 1065-1074.
104. Scheiffele, P., Verkade, P., Fra, A. M., Virta, H., Simons, K., and Iko-nen, E. (1998). Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J. Cell Biol. 140, 795-806.
105. Scherer, P. E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H. F., and Lisanti, M. P. (1996). Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. U.S.A. 93, 131-135.
106. Schnitzer, J. E., Liu, J., and Oh, P. (1995). Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annex-ins, and GTPases. J. Biol. Chem. 270, 14399-14404.
107. Schnitzer, J. E., Oh, P., and McIntosh, D. P. (1996). Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 274, 239-242. [Published erratum appears in Science 1996 Nov 15; 274(5290), 109].
108. Schubert, W., Frank, P. G., Razani, B., Park, D. S., Chow, C. W., and Lisanti, M. P. (2001). Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J. Biol. Chem. 276, 48619-48622.
109. Schubert, W., Frank, P. G., Woodman, S. E., Hyogo, H., Cohen, D. E., Chow, C. W., and Lisanti, M. P. (2002). Microvascular hyper-permeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J. Biol. Chem. 277, 40091-40098.
110. Severs, N. J. (1988). Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J. Cell Sci. 90, 341-348.
111. Shastry, S., Delgado, M. R., Dirik, E., Turkmen, M., Agarwal, A. K., and Garg, A. (2010). Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am. J. Med. Genet. A 152A, 2245-2253.
112. Shatseva, T., Lee, D. Y., Deng, Z., and Yang, B. B. (2011). MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J. Cell. Sci. 124, 2826-2836.
113. Siddiqui, M. R., Komarova, Y. A., Vogel, S. M., Gao, X., Bonini, M. G., Rajasingh, J., Zhao, Y. Y., Brovkovych, V., and Malik, A. B. (2011). Caveolin-1-eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability. J. Cell Biol. 193, 841-850.
114. Smart, E. J., Ying, Y., Donzell, W. C., and Anderson, R. G. (1996). A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271, 29427-29435.
115. Soda, R., and Tavassoli, M. (1984). Transendothelial transport (transcy-tosis) of iron-transferrin complex in the bone marrow. J. Ultrastruct. Res. 88, 18-29.
116. Sonveaux, P., Martinive, P., DeWever, J., Batova, Z., Daneau, G., Pelat, M., Ghisdal, P., Gregoire, V., Dessy, C., Balligand, J. L., and Feron, O. (2004). Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Circ. Res. 95, 154-161.
117. Sowa, G., Pypaert, M., Fulton, D., and Sessa, W. C. (2003). The phos-phorylation of caveolin-2 on ser-ines 23 and 36 modulates caveolin-1-dependent caveolae formation. Proc. Natl. Acad. Sci. U.S.A. 100, 6511-6516.
118. Sowa, G., Pypaert, M., and Sessa, W. C. (2001). Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc. Natl. Acad. Sci. U.S.A. 98, 14072-14077.
119. Sowa, G., Xie, L., Xu, L., and Sessa, W. C. (2008). Serine 23 and 36 phos-phorylation of caveolin-2 is differentially regulated by targeting to lipid raft/caveolae and in mitotic endothelial cells. Biochemistry 47, 101-111.
120. Sun, R. J., Muller, S., Stoltz, J. F., and Wang, X. (2002). Shear stress induces caveolin-1 translocation in cultured endothelial cells. Eur. Bio-phys. J. 30, 605-611.
121. Sun, Y., Hu, G., Zhang, X., and Min-shall, R. D. (2009). Phosphoryla-tion of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and tran-scellular pathways. Circ. Res. 105, 676-685, 15 p following 685.
122. Sundivakkam, P. C., Kwiatek, A. M., Sharma, T. T., Minshall, R. D., Malik, A. B., and Tiruppathi, C. (2009). Caveolin-1 scaffold domain interacts with TRPC1 and IP3R3 to regulate Ca2+ store release-induced Ca2+ entry in endothelial cells. Am. J. Physiol. Cell Physiol. 296, C403- C413.
123. Tagawa, M., Ueyama, T., Ogata, T., Take-hara, N., Nakajima, N., Isodono, K., Asada, S., Takahashi, T., Matsub-ara, H., and Oh, H. (2008). MURC, a muscle-restricted coiled-coil protein, is involved in the regulation of skeletal myogenesis. Am. J. Physiol. Cell Physiol. 295, C490-C498.
124. Tahir, S. A., Yang, G., Goltsov, A. A., Watanabe, M., Tabata, K., Addai, J., Fattahel, M. A., Kadmon, D., and Thompson,T.C. (2008). Tumor cell-secreted caveolin-1 has proangio-genic activities in prostate cancer. Cancer Res. 68, 731-739.
125. Tang, Z., Scherer, P. E., Okamoto, T., Song, K., Chu, C., Kohtz, D. S., Nishi-moto, I., Lodish, H. F., and Lisanti, M. P. (1996). Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271, 2255-2261.
126. Tiruppathi, C., Song, W., Bergenfeldt, M., Sass, P., and Malik, A. B. (1997). Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J. Biol. Chem. 272, 25968-25975.
127. Traub, O., and Berk, B. C. (1998). Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler. Thromb. Vasc. Biol. 18, 677-685.
128. Unno, M., Matsui, T., and Ikeda-Saito, M. (2007). Structure and catalytic mechanism of heme oxygenase. Nat. Prod. Rep. 24, 553-570.
129. Wang, L., Sapuri-Butti, A. R., Aung, H. H., Parikh, A. N., and Rut-ledge, J. C. (2008). Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species. Am. J. Phys-iol. Heart Circ. Physiol. 295, H237- H244.
130. Wang, R., Wang, Z., and Wu, L. (1997). Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br. J. Pharmacol. 121, 927-934.
131. Wang, X. B., Lee, H., Capozza, F., Mar-mon, S., Sotgia, F., Brooks, J. W., Campos-Gonzalez, R., and Lisanti, M. P. (2004). Tyrosine phosphory-lation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27). Biochemistry 43, 13694-13706.
132. Way, M., and Parton, R. G. (1995). M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett. 376, 108-112. [Corrected and repub-lished in FEBS Lett 1996 Jan 2; 378(1):108-112].
133. Williams, K. J., and Tabas, I. (2005). Lipoprotein retention - and clues for atheroma regression. Arterioscler. Thromb. Vasc. Biol. 25, 1536-1540.
134. Woodman, S. E., Ashton, A. W., Schubert, W., Lee, H., Williams, T. M., Medina, F. A., Wyckoff, J. B., Combs, T. P., and Lisanti, M. P. (2003). Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Am. J. Pathol. 162, 2059-2068.
135. Wunderlich, C., Schober, K., Lange, S. A., Drab, M., Braun-Dullaeus, R. C., Kasper, M., Schwencke, C., Schmeisser, A., and Strasser, R. H. (2006). Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure. Biochem. Biophys. Res. Commun. 340, 702-708.
136. Xie, L., Frank, P. G., Lisanti, M. P., and Sowa, G. (2010). Endothelial cells isolated from caveolin-2 knockout mice display higher proliferation rate and cell cycle progression relative to their wild-type counterparts. Am. J. Physiol. Cell Physiol. 298, C693-C701.
137. Xie, L., Vo-Ransdell, C., Abel, B., Willoughby, C., Jang, S., and Sowa, G. (2011). Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor-beta in endothelial cells. Am. J. Physiol. Cell Physiol. 301, C1161-C1174.
138. Yamada, E. (1953). The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1, 445-458.
139. Yang, B., Radel, C., Hughes, D., Kele-men, S., and Rizzo, V. (2011). p190 RhoGTPase-activating protein links the beta1 integrin/caveolin-1 mechanosignaling complex to RhoA and actin remodeling. Arterioscler. Thromb. Vasc. Biol. 31, 376-383.
140. Yang, B., and Rizzo, V. (2007). TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 292, H954-H962.
141. Yang, G., Addai, J., Wheeler, T. M., Frolov, A., Miles, B. J., Kadmon, D., and Thompson, T. C. (2007). Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum. Pathol. 38, 1688-1695.
142. Yu, J., Bergaya, S., Murata, T., Alp, I. F., Bauer, M. P., Lin, M. I., Drab, M., Kurzchalia, T. V., Stan, R. V., and Sessa, W. C. (2006). Direct evidence for the role of caveolin-1 and cave-olae in mechanotransduction and remodeling of blood vessels. J. Clin. Invest. 116, 1284-1291.
143. Zhang, A. Y., Yi, F., Zhang, G., Gulbins, E., and Li, P. L. (2006). Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 47, 74-80.
144. Zhang, Z. B., Cai, L., Zheng, S. G., Xiong, Y., and Dong, J. H. (2009). Over-expression of caveolin-1 in hepa-tocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery. Pathol. Oncol. Res. 15, 495-502.
145. Zhao, Y. Y., Liu, Y., Stan, R. V., Fan, L., Gu, Y., Dalton, N., Chu, P. H., Peterson, K., Ross, J. Jr., and Chien, K. R. (2002). Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc. Natl. Acad. Sci. U.S.A. 99, 11375-11380.
146. Zhao, Y. Y., Zhao, Y. D., Mirza, M. K., Huang, J. H., Potula, H. H., Vogel, S. M., Brovkovych, V., Yuan, J. X., Wharton, J., and Malik, A. B. (2009). Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hyper-tensioninmiceand humans through PKG nitration. J. Clin. Invest. 119, 2009-2018.